4 NHS considerations

System impact

4.1 Approximately 22,500 isolated coronary artery bypass graft (CABG) operations are performed in the UK each year. In addition, a substantial proportion of patients having other cardiac surgery (for example, valve replacement surgery) have concomitant CABG. Based on this large number of patients, any reduction in graft occlusion rates by the MiraQ system during CABG surgery potentially offers significant cost savings to the NHS.

4.2 The committee was informed that the MiraQ system is easy to use and does not significantly increase operative time.

Committee considerations

4.3 As described in section 3, the committee judged that reduction in graft occlusion rates by MiraQ assessment and appropriate revision at the time of surgery could decrease complication rates. This could reduce the likelihood of subsequent interventions, prolonged intensive therapy unit and hospital stay, and readmission. Each of these reductions would result in significant resource savings.

  • National Institute for Health and Care Excellence (NICE)